Zoetis (ZTS) Cash & Equivalents (2012 - 2026)
Zoetis (ZTS) recorded Cash & Equivalents of $1.48 billion in Q2 2026, up 2.9% from $1.44 billion a year earlier but down 24.0% from the prior quarter.
Powered by 
Analysis
Zoetis (ZTS) Cash & Equivalents (2012 - 2026) Analysis & Trends
At the end of FY2025, Zoetis reported Cash & Equivalents of $2.45 billion, up 23.3% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -7.4% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $1.99 billion in FY2024 (-2.6%), $2.04 billion in FY2023 (-43.0%), $3.58 billion in FY2022 (+2.8%) and $3.49 billion in FY2021 (-3.3%).
- Quarterly Cash & Equivalents has ranged from $1.44 billion in Q2 2025 to $3.58 billion in Q4 2022 over the past five years.
- On a year-over-year basis, Cash & Equivalents has increased for four consecutive quarters, with growth averaging 4.2% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 23.3% in Q4 2025, against a decline of 43.0% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.94 billion (Q1 2026), $2.45 billion (Q4 2025) and $2.08 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Zoetis | 28.86 Bn | 20.71 Bn | 1.05 Bn | 1.48 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.48 Bn |
| Mar 31, 2026 | 1.94 Bn |
| Dec 31, 2025 | 2.45 Bn |
| Sep 30, 2025 | 2.08 Bn |
| Jun 30, 2025 | 1.44 Bn |
| Mar 31, 2025 | 1.72 Bn |
| Dec 31, 2024 | 1.99 Bn |
| Sep 30, 2024 | 1.71 Bn |
| Jun 30, 2024 | 1.57 Bn |
| Mar 31, 2024 | 1.98 Bn |
| Dec 31, 2023 | 2.04 Bn |
| Sep 30, 2023 | 1.75 Bn |
| Jun 30, 2023 | 1.72 Bn |
| Mar 31, 2023 | 2.11 Bn |
| Dec 31, 2022 | 3.58 Bn |
| Sep 30, 2022 | 2.51 Bn |
| Jun 30, 2022 | 2.65 Bn |
| Mar 31, 2022 | 3.14 Bn |
| Dec 31, 2021 | 3.49 Bn |
| Sep 30, 2021 | 3.27 Bn |
API Access
Zoetis Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ZTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ZTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ZTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();